Skip to main content
Clinical Trials/ITMCTR2023000053
ITMCTR2023000053Not yet recruitingPhase 1

A multicentre pre-randomised clinical study of Xiao'er Jiangqi Pingxiao Heji in the treatment of asthma exacerbations in children

anjing University of Chinese Medicine0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
3 to 12 (—)
Sex
All

Inclusion Criteria

  • 1. Anyone who meets the diagnostic criteria of western medicine and the syndrome criteria of external cold and internal heat syndrome of traditional Chinese medicine;
  • 2. Age between 3 and 12 years old, regardless of gender;
  • 3. Acute onset, according to the judgment standard, the condition is mild or moderate;
  • 4. No treatment has been given in the past 3 days after the onset.

Exclusion Criteria

  • 1. Stable condition or in asthma remission;
  • 2. Severe asthma, status asthmaticus, critically ill patients, and patients with pulmonary infection;
  • 3. Those who are accompanied by other diseases that cause asthma or dyspnea in patients and affect the evaluation of curative effect;
  • 4. Patients with primary diseases such as cardiovascular and cerebrovascular, liver and kidney, and hematopoietic system;
  • 5. Those who are allergic to the ingredients of this study.

Investigators

Sponsor
anjing University of Chinese Medicine

Similar Trials